193 related articles for article (PubMed ID: 37482993)
1. A 14-Year Longitudinal Analysis of Healthcare Expenditure on Dementia and Related Factors (DEMENCOST Study).
Inoriza JM; Carreras M; Coderch J; Turro-Garriga O; Sáez M; Garre-Olmo J
J Alzheimers Dis; 2023; 95(1):131-147. PubMed ID: 37482993
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity in Dementia Diseases and Associated Health Care Resources Utilization and Cost.
Kaczynski A; Michalowsky B; Eichler T; Thyrian JR; Wucherer D; Zwingmann I; Hoffmann W
J Alzheimers Dis; 2019; 68(2):635-646. PubMed ID: 30856111
[TBL] [Abstract][Full Text] [Related]
3. Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data.
Schwarzkopf L; Menn P; Leidl R; Wunder S; Mehlig H; Marx P; Graessel E; Holle R
BMC Health Serv Res; 2012 Jun; 12():165. PubMed ID: 22713212
[TBL] [Abstract][Full Text] [Related]
4. Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial.
Michalowsky B; Flessa S; Eichler T; Hertel J; Dreier A; Zwingmann I; Wucherer D; Rau H; Thyrian JR; Hoffmann W
Eur J Health Econ; 2018 Jan; 19(1):87-102. PubMed ID: 28160100
[TBL] [Abstract][Full Text] [Related]
5. [The economic and social burden of dementia diseases in Germany-A meta-analysis].
Michalowsky B; Kaczynski A; Hoffmann W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Aug; 62(8):981-992. PubMed ID: 31297549
[TBL] [Abstract][Full Text] [Related]
6. Simulation of health care and related costs in people with dementia in Australia.
Standfield L; Comans T; Scuffham PA
Aust Health Rev; 2019 Oct; 43(5):531-539. PubMed ID: 30244690
[TBL] [Abstract][Full Text] [Related]
7. 2021 Alzheimer's disease facts and figures.
Alzheimers Dement; 2021 Mar; 17(3):327-406. PubMed ID: 33756057
[TBL] [Abstract][Full Text] [Related]
8. Economic Analysis of Formal Care, Informal Care, and Productivity Losses in Primary Care Patients who Screened Positive for Dementia in Germany.
Michalowsky B; Thyrian JR; Eichler T; Hertel J; Wucherer D; Flessa S; Hoffmann W
J Alzheimers Dis; 2016; 50(1):47-59. PubMed ID: 26639964
[TBL] [Abstract][Full Text] [Related]
9. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
10. Cost of disorders of the brain in Europe 2010.
Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
[TBL] [Abstract][Full Text] [Related]
11. Costs of Dementia in Low- And Middle-Income Countries: A Systematic Review.
Kenne Malaha A; Thébaut C; Achille D; Preux PM; Guerchet M
J Alzheimers Dis; 2023; 91(1):115-128. PubMed ID: 36404540
[TBL] [Abstract][Full Text] [Related]
12. Incremental healthcare expenditure attributable to diabetes mellitus: A cost of illness study in Tasmania, Australia.
Dinh NTT; de Graaff B; Campbell JA; Jose MD; Burgess J; Saunder T; Kitsos A; Wiggins N; Palmer AJ
Diabet Med; 2022 Jun; 39(6):e14817. PubMed ID: 35181930
[TBL] [Abstract][Full Text] [Related]
13. The main cost drivers in dementia: a systematic review.
Schaller S; Mauskopf J; Kriza C; Wahlster P; Kolominsky-Rabas PL
Int J Geriatr Psychiatry; 2015 Feb; 30(2):111-29. PubMed ID: 25320002
[TBL] [Abstract][Full Text] [Related]
14. Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.
Parasuraman S; Thiel E; Park J; Teschemaker A
J Med Econ; 2023; 26(1):454-462. PubMed ID: 36883994
[TBL] [Abstract][Full Text] [Related]
15. Health, social and economic consequences of dementias: a comparative national cohort study.
Frahm-Falkenberg S; Ibsen R; Kjellberg J; Jennum P
Eur J Neurol; 2016 Sep; 23(9):1400-7. PubMed ID: 27297659
[TBL] [Abstract][Full Text] [Related]
16. Who Benefits Most from Collaborative Dementia Care from a Patient and Payer Perspective? A Subgroup Cost-Effectiveness Analysis.
Rädke A; Michalowsky B; Thyrian JR; Eichler T; Xie F; Hoffmann W
J Alzheimers Dis; 2020; 74(2):449-462. PubMed ID: 32039839
[TBL] [Abstract][Full Text] [Related]
17. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
18. Burden of Crohn's disease in the United States: long-term healthcare and work-loss related costs.
Manceur AM; Ding Z; Muser E; Obando C; Voelker J; Pilon D; Kinkead F; Lafeuille MH; Lefebvre P
J Med Econ; 2020 Oct; 23(10):1092-1101. PubMed ID: 32609019
[TBL] [Abstract][Full Text] [Related]
19. Incremental Health Care Expenditure of Chronic Cutaneous Ulcers in the United States.
Tripathi R; Knusel KD; Ezaldein HH; Honaker JS; Bordeaux JS; Scott JF
JAMA Dermatol; 2019 Jun; 155(6):694-699. PubMed ID: 30892572
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
